Buchi J Kevin's Form 4 filing
Ampio Pharmaceuticals, Inc. (AMPE) · filed Jun 13, 2023
- Accession no.
- 0001615594-23-000047
- Filed
- Jun 13, 2023, 12:07 PM ET
- Trade date
- Jun 9, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $6.28K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buchi J KevinCIK 0001209726 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | Common Stock | PPurchaseAcquired | +21,858 | $0.2875F1 | +$6,284.18 | 146,858 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $0.2751 to $0.30, inclusive.
Referenced by the price of 1 transaction in Table I.